Portfolio company
Functional Fluidics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops red blood cell function assays and biomarkers for pharmaceutical firms, biotech partners and clinical providers to monitor sickle cell disease treatments.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Forma Therapeutics
This company develops medicines for patients with sickle cell disease and rare blood disorders.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Forma
This company develops small molecule therapies for patients with sickle cell disease and cancer.
IMMvention Therapeutics
This biotechnology firm develops small molecule oral therapies for patients with sickle cell disease and other inflammatory or neurodegenerative conditions.
LiquidCell Dx
This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.
Global Blood Therapeutics
This biopharmaceutical company develops and manufactures oral medicines to treat sickle cell disease for patients and healthcare providers.
Disc Medicine
This biopharmaceutical company develops novel therapeutic candidates to treat patients suffering from serious haematologic diseases by targeting red blood cell biology and iron homeostasis.
Ferritiva
This company develops non-invasive diagnostic strips and sensors for monitoring iron deficiency using saliva or urine samples for athletes and at-risk populations.
